$7.17+3.2%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 9, 2026
Company outlook: revenue of $825M to $830M for Fiscal year 2026 — up 0.6% on a year earlier
Just reported
From Orthofix Medical Inc.'s results release of November 9, 2026; its quarterly report has since been filed.
Actual
$207.9M
+1.1% y/y
-1.5% q/q
Guided
—
No guide given
Actual
-$0.15
Guided
—
No guide given
Actual
$1.5M
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $207.9M | $205.6M | +1.08% |
| Profit | -$6.1M | -$22.8M | +73.35% |
| Profit per share | -$0.15 | -$0.57 | +73.68% |
| Free Cash Flow | -$14.1M | $2.5M | -666.01% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Orthofix Medical Inc. reported on November 9, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“Continued growth in Limb Reconstruction and Therapeutic Solutions helped offset weaker Spine performance,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Orthofix is a global medical technology company dedicated to advancing healing and restoring mobility for patients with complex musculoskeletal conditions. Headquartered in Lewisville, Texas, the Company offers a differentiated portfolio of spinal implants, therapeutic solutions, limb reconstruction systems, biologics and enabling technologies, including the 7D FLASH Navigation System. Orthofix’s technology-enabled solutions are designed to support surgeons across the continuum of care and improve outcomes for patients. Learn more at Orthofix.com and follow Orthofix on LinkedIn .
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Orthofix Medical Inc.’s Item 2.02 8-K filed November 9, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.